Veru Inc EV/EBITDA
What is the EV/EBITDA of Veru Inc?
The EV/EBITDA of Veru Inc is N/A
What is the definition of EV/EBITDA?
EV/EBITDA is enterprise value divided by earnings before interest, tax, depreciation, and amortization. It is a measure of how expensive a stock is and is more frequently valid for comparisons across companies than the price to earnings ratio. It measures the price (in the form of enterprise value) an investor pays for the benefit of the company’s cash flow (in the form of EBITDA).
= enterprise value / EBITDA
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA of companies in the Health Care sector on NASDAQ compared to Veru Inc
What does Veru Inc do?
the female health company/veru healthcare is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. to realize this goal, veru healthcare has three divisions: pharmaceutical and devices, consumer health products, and public sector. for men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout, and sexual dysfunction. women’s health has product candidates for female sexual health and advanced breast and ovarian cancers and markets fc2, a disposable contraceptive device, to ob gyn physicians and is the only female condom approved by fda that offers dual protection against sexually transmitted infections, including hiv/aids and the zika virus, and unintended pregnancy. since the female health company began distributing fc2 in 2007, the product has been shipped to 144 countries
Companies with ev/ebitda similar to Veru Inc
- Annovis Bio has EV/EBITDA of N/A
- Newtopia has EV/EBITDA of N/A
- Branded Legacy Inc has EV/EBITDA of N/A
- 23228 has EV/EBITDA of N/A
- Centurion Minerals has EV/EBITDA of N/A
- URA Plc has EV/EBITDA of N/A
- Veru Inc has EV/EBITDA of N/A
- Dynamo Capital has EV/EBITDA of N/A
- Esports Mogul has EV/EBITDA of N/A
- FireFox Gold has EV/EBITDA of N/A
- SecureWorks Corp has EV/EBITDA of N/A
- Armada Metals Ltd has EV/EBITDA of N/A
- BriaCell Therapeutics has EV/EBITDA of N/A